Cannara Biotech Inc. has announced that it has entered into an automatic share purchase plan with Raymond James Ltd., acting as Cannara’s broker, in order to facilitate repurchases of the company’s common shares under its previously announced normal course issuer bid. Cannara previously announced in November 2022 , that it had received approval from the TSX-V to purchase up to 1,500,000 of its common shares, representing approximately 1.7% of the total common shares.

Cannara Biotech Inc., a Bristol Invetor Relations client, is a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec.

Read the full press release here: Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan